[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (2): 155-159.doi: 10.3736/jcim20070211

• Original Experimental Research • Previous Articles     Next Articles

Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice

Wei Gu, Ke-qi Han, Yong-hua Su, Xue-qiang Huang, Chang-quan Ling   

  1. Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Online:2007-03-31 Published:2007-03-15

Objective: To investigate the anti-tumor effect of bufalin and its regulation on Bcl-2 and Bax proteins in orthotopically transplanted tumor of human hepatocellular carcinoma in nude mice. 

Methods: Orthotopically transplanted tumor of human hepatocellular carcinoma was established in nude mice. The mice were randomly divided into five groups: high-dose bufalin-treated group (1.5 mg/kg), medium-dose bufalin-treated group (1 mg/kg), low-dose bufalin-treated group (0.5 mg/kg), adriamycin-treated group (8.0 mg/kg), and normal saline-treated group. After 25 days, mice were sacrificed. The tumor volume was measured, and the pathological changes of tumor tissues were detected by HE staining to observe the tumor necrosis degree. Cell morphological changes were also observed by an electron microscopy. Label index of tumor cell apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), and the expressions of Bcl-2 and Bax proteins were determined by immunohistochemical method. 

Results: The tumor volume in the bufalin-treated groups was shrunk significantly compared with that in the normal saline-treated group (P<0.01). The survival time of the bufalin-treated groups was prolonged compared with that of the adriamycin-treated group and the normal saline-treated group (P<0.05). Apoptotic characteristics could be seen in tumor tissues of the bufalin-treated groups. The label index of tumor cell apoptosis in the bufalin-treated groups (5.87±2.13, 8.86±2.96 and 10.60±3.42 in low-, medium- and high-dose groups respectively) was higher than that in the adriamycin-treated group (3.28 ±0.98) (P<0.05, P<0.01). The expression of Bax was up-regulated, while no changes were detected as to Bcl-2 protein in tumors of the bufalin-treated groups.

Conclusion: Bufalin has significant anti-tumor effect on the orthotopically transplanted tumor of human hepatocellular carcinoma in nude mice. Its effect might be related to up-regulation of Bax protein and inducement of the tumor cell apoptosis.

Key words: bufalin, liver neoplasms, apoptosis, Bcl-2, Bax, nude mice

CLC Number: 

  • R735.7

Table 1

Changes of mouse body weight and tumor volume of human hepatocellular orthotopically transplanted tumor induced by bufalin ($\bar{x}±S$)"

GroupnBody weight (g)Tumor volume (mm3)Tumor inhibition rate
Pre-treatmentPost-treatmentPre-treatmentPost-treatment
High-dose bufalin-treated1020.94±1.0021.39±1.62*43.50±5.0935.21±12.51△△79.3%*
Medium-dose bufalin-treated1020.03±1.1621.48±1.10*42.92±4.1049.83±11.46△△ 70.70%
Low-dose bufalin-treated1021.06±0.9421.57±1.14*43.00±2.9783.99±24.63△△ 50.70%
ADM-treated1021.00±1.0018.90±0.7742.93±4.2355.17±16.13△△ 67.60%
NS-treated1020.95±1.0720.40±1.2343.37±4.82170.39±25.291

Figure 1

Mean survival time of five groupsBu1: High-dose bufalin-treated group; Bu2: Medium-dose bufalin-treated group; Bu3: Low-dose bufalin-treated group; *P<0.05, vs NS-treated group; n=5"

Figure 2

Pathological characteristics of tumor necrosi (HE staining, ×250)A: NS-treated group; B: High-dose bufalin-treated group."

Table 2

Label index of tumor cell apoptosis and expressions of Bcl-2 and Bax in tumor tissues ($\bar{x}±S$)"

GroupnLabel index (%)
ApoptosisBcl-2Bax
High-dose bufalin-treated1010.60±3.42**8.76±5.1890.70±16.82**
Medium-dose bufalin-treated108.86±2.96**8.52±3.5780.21±21.23**
Low-dose bufalin-treated105.87±2.13*11.34±6.2479.54±10.75**
ADM-treated104.26±2.1210.59±6.9247.56±15.31*
NS-treated103.28±0.989.05±4.9731.25±12.50

Figure 3

Expression of Bax in orthotopically transplanted tumor of humanhepatocellular carcinoma in nude mice (SP method, ×200) A: Bax expressed weakly in NS-treated group. B: High expression in high-dose bufalin-treated group."

[1] Yamada K, Hino K, Tomoyasu S.et al.Enhancement by bufalin of retinoic acid induced differentiation of acute promyelocytic leukemia cells in primary culture[J].Leuk Res,1998,22(7):589-595
Yamado K, Hino K, Tomoyasu S.et al.Enhancement by bufalin of retinoic acid induced differentiation of acute promyelocytic leukemia cells in primary culture[J].Leuk Res,1998,22(7):589-595
[2] Yeh JY, Huang WJ, Kan SF, et al.Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells[J].Prostate,2003,54(2):112-124
[3] 陈小义, 徐瑞成, 陈莉, 等.蟾蜍灵诱导人胃癌细胞凋亡的实验研究[J].基础医学与临床,2000,20(5):50-53
Chen XY, Xu RC, Chen L, et al.Apoptosis of gastric cancer cells induced by bufalin[J].Ji Chu Yi Xue Yu Lin Chuang,2000,20(5):50-53
[4] 顾伟, 韩克起, 苏永华, 等.蟾毒灵对人肝癌BEL-7402细胞增殖的影响[J].中西医结合肝病杂志,2006,16(1):16-17, 20
Gu W, Han KQ, Su YH, et al.Effect of bufalin on proliferation of BEL-7402 human hepatocarcinoma cell line[J].Zhong Xi Yi Jie He Gan Bing Za Zhi,2006,16(1):16-17, 20
[5] 顾伟, 沈婕, 翟笑枫.大鼠移植性肝癌模型生物学行为与分期的初步探讨[J].中西医结合学报,2005,3(2):136-138
Gu W, Shen J, Zhai XF.Preliminary study on biological behavior and staging of transplanted hepatoma in rats[J].Zhong Xi Yi Jie He Xue Bao,2005,3(2):136-138
[6] 韩克起, 顾伟, 张亚妮, 等.裸鼠人肝癌原位移植模型的建立[J].第四军医大学学报,2004,25(17):
Han KQ, Gu W, Zhang YN, et al.Establishment of orthotopic transplantation tumor models of human hepatocellular carcinoma in nude mice[J].Di Si Jun Yi Da Xue Xue Bao,2004,25(17):inside front cover
[7] 李琦, 范忠泽, 李先茜, 等.去甲斑蝥素微球介入治疗大鼠肝癌疗效及其机制研究[J].中西医结合学报,2006,4(4):378-383
Li Q, Fan ZZ, Li XQ, et al.Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism[J].Zhong Xi Yi Jie He Xue Bao,2006,4(4):378-383
[8] 陈喆, 翟笑枫, 苏永华, 等.华蟾素注射液治疗中晚期原发性肝癌临床疗效观察[J].中西医结合学报,2003,1(3):184-186
Chen Z, Zhai XF, Su YH, et al.Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer[J].Zhong Xi Yi Jie He Xue Bao,2003,1(3):184-186
[9] Kamano Y, Nogawa T, Yamashita A, et al.Isolation and structure of a 20, 21-epoxybufenolide series from ''Ch'an Su''[J].J Nat Prod,2002,65(7):1001-1005
doi: 10.1194/jlr.M900181-JLR200 pmid: 12141860
[10] 苏永华, 牛欣.蟾酥制剂的药效作用研究评述[J].北京中医药大学学报,2001,24(2):51-54
Su YH, Niu X.Pharmacodynamic research of ''Ch'an Su'' praeparatum: a review[J].Beijing Zhong Yi Yao Da Xue Xue Bao,2001,24(2):51-54
[11] 苏永华, 尹西才, 谢觉民, 等.三种蟾毒单体对SMMC-7721和BEL-7402人肝癌细胞生长的抑制作用[J].第二军医大学学报,2003,24(4):393-395
Su YH, Yin XC, Xie JM, et al.Inhibition effects of three kinds of bufotoxins on human SMMC-7721 and BEL-7402 hepatoma cell lines[J].Di Er Jun Yi Da Xue Xue Bao,2003,24(4):393-395
[12] 江苏新医学院.中药大辞典[M].上海: 上海科学技术出版社,1977,():84-85
Jiangsu New Medical College.Dictionary of Chinese Traditional Drugs[M].Shanghai: Shanghai Scientific and Technical Publishers,1977,():84-85
[13] Cory S, Adams JM.Killing cancer cells by flipping the Bcl-2/Bax switch[J].Cancer Cell,2005,8(1):5-6
doi: 10.1016/j.ccr.2005.06.012 pmid: 16023593
[14] Terada T, Nakanuma Y.Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigen(bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas[J].Pathol Int,1996,46(10):764-770
[1] Avijit Paul, Kausik Bishayee, Samrat Ghosh, Avinaba Mukherjee, Sourav Sikdar, Debrup Chakraborty, Naoual Boujedaini, Anisur Rahman Khuda-Bukhsh. Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways. Journal of Chinese Integrative Medicine, 2012, 10(9): 1025-1038.
[2] Yogesh Bendale, Vineeta Bendale, Saili Paul, Soumya Sundar Bhattacharyya. Green synthesis, characterization and anticancer potential of platinum nanoparticles Bioplatin. Journal of Chinese Integrative Medicine, 2012, 10(6): 681-689.
[3] Hui-qing Zhang , Zi-fei Yin , Jia-yu Sheng , Zhu-qian Jiang , Bao-yu Wu , Yong-hua Su. A comparison study of pharmacokinetics between bufalin-loaded bovine serum albumin nanoparticles and bufalin in rats. Journal of Chinese Integrative Medicine, 2012, 10(6): 674-680.
[4] Yue-hua Wang, Xiao-li He, Xiao-xiu Li, Hai-lin Qin, Guan-hua Du . Effects of the effective component group of Chinese herbal medicine Xiaoxuming Decoction on brain mitochondria in rats with chronic cerebral ischemia. Journal of Chinese Integrative Medicine, 2012, 10(5): 569-576.
[5] Min Zhu , Mi Zhou , Ying Shi , Wen-wei Li. Effects of echinacoside on MPP+-induced mitochondrial fragmentation, mitophagy and cell apoptosis in SH-SY5Y cells. Journal of Chinese Integrative Medicine, 2012, 10(12): 1427-1432.
[6] Mukherjee Avinaba, Sikdar Sourav, Bishayee Kausik, Paul Avijit, Ghosh Samrat, Boujedaini Naoual, Rahman Khuda-Bukhsh Anisur. Ethanolic extract of Thuja occidentalis blocks proliferation of A549 cells and induces apoptosis in vitro. Journal of Chinese Integrative Medicine, 2012, 10(12): 1451-1459.
[7] Samadder Asmita, Das Jayeeta, Das Sreemanti, Das Durba, De Arnab, Bhadra Kakali, Rahman Khuda-Bukhsh Anisur. Dihydroxy-isosteviol methyl ester of Pulsatilla nigricans extract reduces arsenic-induced DNA damage in testis cells of male mice: Its toxicity, drug-DNA interaction and signaling cascades. Journal of Chinese Integrative Medicine, 2012, 10(12): 1433-1442.
[8] Agung E. Nugroho, Adam Hermawan, Dyaningtyas D. P. Putri, E. dY Meiyanto, Lukman Hakim . Synergistic effects of ethyl acetate fraction of Ficus septica Burm. f. and doxorubicin chemotherapy on T47D human breast cancer cell line. Journal of Chinese Integrative Medicine, 2012, 10(10): 1162-1170.
[9] Xiao-ping Huang , Xiao-dan Liu , Chang-qing Deng . Effects of the combination of active component extracts from Astragalus membranaceus and Panax notoginseng on apoptosis, reactive oxygen species and mitochondrial membrane potential of PC12 cells with oxidative injury. Journal of Chinese Integrative Medicine, 2012, 10(10): 1127-1134.
[10] Hao Dai, Jun Gu, Ling-zhi Li, Li-mei Yang, Hui Liu, Jian-yu Li. Scutellarin benzyl ester partially secured the ischemic injury by its anti-apoptosis mechanism in cardiomyocytes of neonatal rats. Journal of Chinese Integrative Medicine, 2011, 9(9): 1014-1021.
[11] Lan Chen, Hui Li, Chun Li, Jia-hui Cao, Yi-ling Wu, Yang Liu, Jian-hong Zhou, Dong-feng Chen, Yi-wei Li. Active ingredients of Plastrum Testudinis inhibit epidermal stem cell apoptosis in serum-deprived culture. Journal of Chinese Integrative Medicine, 2011, 9(8): 888-893.
[12] Yu Miao, Yue-rong Jiang, Lin Yang, Cheng-dong Xia, Lu Zhang, Cai-feng Wu, Da-zhuo Shi, Hui-jun Yin, Ke-ji Chen. Effects of Chinese herbal drug-containing serum on oxidative damage and apoptosis of umbilical vein endothelial cells induced by oxidized low-density lipoprotein. Journal of Chinese Integrative Medicine, 2011, 9(5): 539-545.
[13] Zhao-hui Chu, Xiao-hua Liang, Xin-li Zhou, Ruo-fan Huang, Qiong Zhan, Jing-wei Jiang. Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway. Journal of Chinese Integrative Medicine, 2011, 9(5): 533-538.
[14] Bo Yang, Xue-chun Lu, Feng Zhang, Yang Liu, Hong-li Zhu. Inhibitory effects of traditional Chinese herbal medicine Tanreqing injection on proliferation of leukemia cells in vitro and the potential mechanisms. Journal of Chinese Integrative Medicine, 2011, 9(4): 414-422.
[15] Khuda-Bukhsh AR, Bhattacharyya SS, Paul S, Boujedaini N. Polymeric nanoparticle encapsulation of a naturally occurring plant scopoletin and its effects on human melanoma cell A375. Journal of Chinese Integrative Medicine, 2010, 8(9): 853-862.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]